GENinCode UK Ltd. (GB:GENI) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
GENinCode UK Ltd. presented new findings at the European Society of Cardiology Congress, demonstrating that CARDIO inCode-Score® can predict coronary heart disease (CHD) risk by considering both genetic factors and family history. The study showed a significant increase in CHD risk with a high polygenic risk score and positive family history, emphasizing the need for a comprehensive approach to preventive care. The company’s technology aims to enhance patient risk assessment, facilitating earlier and more effective interventions for those at high genetic risk of CHD.
For further insights into GB:GENI stock, check out TipRanks’ Stock Analysis page.